Symposia at Scientific Sessions 2025

Friday, Nov. 7, 2025, 1:00 p.m. to 5:00 p.m.

This half-day program will provide foundational educational content for clinicians seeking to optimize approaches to CKM syndrome care. The format of the course will be to provide practical lectures regarding the science and clinical management of CKM syndrome, complemented by interactive, case-based practicum sessions to inform application of management principles in clinical practice.

Learning Objectives:

1. Interpret pathophysiological interactions among metabolic risk factors such as obesity and diabetes, chronic kidney disease (CKD) and the cardiovascular system.
2. Present the CKM staging model to facilitate prevention and treatment efforts.
3. Apply the PREVENT™ calculator for primary prevention patients (those without coronary heart disease, stroke, or heart failure) who are between the ages of 30-79 years.
4. Integrate prevention and management strategies across the CKM syndrome stages.
5. Assess the heterogeneity in metabolic disease and the impact of social determinants of health (SDOH) when determining the propensity for metabolic risk factors.

Please note: this event requires a separate registration and fee.

Friday, Nov. 7, 2025, 1:00 p.m. to 5:00 p.m.

Attend this bootcamp to be eligible to submit an upcoming AHA grant proposal using Get With The Guidelines® (GWTG) data with a deadline following Scientific Sessions. The AHA's GWTG data includes more than 14 million patient records across 5 programs. Researchers must use the Precision Medicine Platform to access and analyze this data.

This requires coding experience in R, Python, or SAS or bringing a researcher that has these skills. Each person must register separately. There will be 1-2 pre-requisite virtual meetings prior to the onsite event in New Orleans.

You must register before October 27, 2025.

This bootcamp requires a separate registration & fee.

Friday, Nov. 7, 2025, 12:30 p.m. to 5:15 p.m.

Join leading global experts in cardiovascular and stroke medicine for an exclusive half-day event dedicated to the latest American Heart Association (AHA) clinical practice guidelines. Dive into three dynamic panel discussions that will provide a global perspective on the 2025 guidelines for high blood pressure, acute coronary syndrome, and resuscitation.

Why Attend?

• Engage with Pioneers: Connect with leading professionals who are shaping the future of cardiovascular care outside the United States.
• Interactive Panels: Participate in lively discussions that will explore evidence-based practice changes, implementation strategies, and research opportunities.
• Global Insights: Gain valuable insights into how these guidelines can be adapted and applied across diverse geographic and clinical settings.

Don't miss this unique opportunity to be at the forefront of cardiovascular innovation.

Friday, Nov. 7, 2025, 8:00 a.m. to 4:45 p.m.

The Quality of Care and Outcomes Research Scientific Sessions, an American Heart Association sponsored meeting, will be held Friday, November 7, 2025, at the Ernest N. Morial Convention Center in New Orleans, Louisiana.

The QCOR Scientific Sessions features a state-of-the-art curriculum with a broad appeal to the target audience of clinicians, researchers, medical students and trainees, nurses, pharmacists, administrators, healthcare and managed care professionals, policymakers, and other professionals interested in the quality of care and outcomes research in cardiovascular disease and stroke.

Genomic and Precision Medicine Symposium – Model Systems: Preclinical to Phase I Bridge
Friday, Nov. 7, 2025, 12:30 p.m. to 5:15 p.m.

This program will explore the Genotype-specific treatment strategies for cardiovascular disease that are in trials and development. Traditional animal models of disease lack a human genetic background, partially limiting the applicability of the models to study genetic testing and disease-specific therapeutics.

The FDA Reauthorization Act 2.0 allows for the use of non-animal testing to assess the safety and efficacy of therapeutics, but there is little guidance on how to actualize this in practice. Non-animal preclinical models, including patient-specific induced pluripotent stem cells, are likely to become increasingly more important. This session aims to capture this rapidly advancing field, including the spectrum of model systems, the cardiovascular disease types that can be captured, the therapeutic strategies that can be assessed and the evolving landscape of regulation.

Friday, Nov. 7, 2025, 12:30 p.m. to 5:15 p.m.

At the 2025 AHA Scientific Sessions, clinicians will receive key updates on managing hypertension and chronic kidney disease (CKD), especially in patients with heart failure. Highlights include a deep dive into the 2025 AHA Blood Pressure Guideline and CKD management, featuring insights from the writing group and global experts.

Sessions will also cover practical strategies for managing CKD in HFpEF and tailoring cardio-renal therapies—such as RAAS inhibitors, SGLT2 inhibitors, and MRAs—across all stages of kidney disease, including ESRD and post-transplant care.